Zinger Key Points
- Redwoods Acquisition's shares surge as shareholders green-light merger with Anew Medical, valuing the combined entity at $94 million.
- Despite prior challenges, including a Nasdaq delinquency notice, the transaction anticipates generating $54 million in cash proceeds.
- Get New Picks of the Market's Top Stocks
Redwoods Acquisition Corp. RWOD shares traded higher on Friday after the company announced that shareholders had approved its merger agreement with Anew Medical.
Following the consummation of the transactions, Redwoods will change its name to Anew Medical, the company said in an exchange filing (April 18).
On May 30, 2023, Redwoods Acquisition entered into a business combination agreement with Anew Medical Sub, Inc.
The transaction values the combined company at a pro forma enterprise value of approximately $94.0 million, with existing ANEW stockholders rolling over 100% of their equity into the combined company.
The transaction is expected to provide approximately $54 million of cash proceeds, assuming no redemptions by Redwoods stockholders.
According to Benzinga Pro, RWOD stock has lost over 22% in the past year.
Last year, the company received a delinquency notification letter from Nasdaq due to its failure to timely file its Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2023.
Price Action: RWOD shares are trading higher by 53.80% to $12.30 at the last check Wednesday.
Image via Shutterstock
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
